Masayuki Kurata

1.0k total citations
24 papers, 733 citations indexed

About

Masayuki Kurata is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Masayuki Kurata has authored 24 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Masayuki Kurata's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (4 papers). Masayuki Kurata is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (4 papers). Masayuki Kurata collaborates with scholars based in Japan and United States. Masayuki Kurata's co-authors include Momoko Nishikori, Takashi Uchiyama, Tomomi Sakai, Masakatsu Hishizawa, T Hayashi, Masaharu Tashima, Toshio Heike, Tadakazu Kondo, Ryō Yamamoto and Katsuyuki Ohmori and has published in prestigious journals such as Blood, Oncogene and Genetics.

In The Last Decade

Masayuki Kurata

24 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Kurata Japan 12 344 341 246 167 152 24 733
Stephan Kreher Germany 15 216 0.6× 160 0.5× 251 1.0× 160 1.0× 174 1.1× 26 700
Maria Luisa Lombardi Italy 17 469 1.4× 110 0.3× 213 0.9× 212 1.3× 122 0.8× 38 832
Ayako Masaki Japan 17 179 0.5× 404 1.2× 238 1.0× 55 0.3× 196 1.3× 77 913
Kyohei Yamada Japan 14 213 0.6× 196 0.6× 223 0.9× 78 0.5× 96 0.6× 57 528
Quangeng Zhang China 9 163 0.5× 134 0.4× 229 0.9× 99 0.6× 352 2.3× 12 747
Barbara Hutter Germany 16 107 0.3× 160 0.5× 38 0.2× 80 0.5× 413 2.7× 33 751
J. Kimble Frazer United States 12 134 0.4× 214 0.6× 193 0.8× 37 0.2× 355 2.3× 33 684
Yujie Wu China 15 236 0.7× 183 0.5× 249 1.0× 298 1.8× 170 1.1× 91 681
L Nagarajan United States 15 119 0.3× 142 0.4× 79 0.3× 87 0.5× 497 3.3× 28 764
Benjamin E. Rich United States 15 84 0.2× 151 0.4× 390 1.6× 98 0.6× 238 1.6× 29 757

Countries citing papers authored by Masayuki Kurata

Since Specialization
Citations

This map shows the geographic impact of Masayuki Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Kurata more than expected).

Fields of papers citing papers by Masayuki Kurata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Kurata. The network helps show where Masayuki Kurata may publish in the future.

Co-authorship network of co-authors of Masayuki Kurata

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Kurata. A scholar is included among the top collaborators of Masayuki Kurata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Kurata. Masayuki Kurata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurata, Masayuki, et al.. (2014). Sugar Beet (Beta vulgaris L.). Methods in molecular biology. 335–347. 21 indexed citations
2.
Arima, Hiroshi, Hayato Maruoka, Sumie Tabata, et al.. (2013). Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma. Leukemia & lymphoma. 54(12). 2645–2653. 12 indexed citations
3.
Aoki, Kazunari, Takayuki Takahashi, Sumie Tabata, et al.. (2013). Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 54(11). 2441–2447. 23 indexed citations
4.
Tabata, Sumie, Masayuki Kurata, June Takeda, et al.. (2012). [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma].. PubMed. 53(11). 1906–10. 3 indexed citations
5.
Matsuhira, Hiroaki, Masayuki Kurata, Kazuyoshi Kitazaki, et al.. (2012). Unusual and Typical Features of a NovelRestorer-of-FertilityGene of Sugar Beet (Beta vulgarisL.). Genetics. 192(4). 1347–1358. 71 indexed citations
6.
Shimoji, Sonoko, Hayato Maruoka, Daichi Inoue, et al.. (2011). [Exacerbation of autoimmune neutropenia to agranulocytosis in association with severe autoimmune thrombocytopenia and hemolytic anemia in a patient with Sjögren's syndrome].. PubMed. 52(7). 535–9. 2 indexed citations
7.
Nagai, Yuya, Kazuhiro Ikegame, Minako Mori, et al.. (2010). Hepatosplenic αβ T cell lymphoma. International Journal of Clinical Oncology. 15(2). 215–219. 7 indexed citations
8.
Tabata, Sumie, Sonoko Shimoji, Kimihiko Murase, et al.. (2009). Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis. International Journal of Hematology. 90(3). 407–412. 19 indexed citations
9.
Katayama, Minako, Yukihiro Imai, Hisako Hashimoto, et al.. (2009). Fulminant fatal cardiotoxicity following cyclophosphamide therapy. Journal of Cardiology. 54(2). 330–334. 51 indexed citations
10.
Togami, Katsuhiro, Yuya Nagai, Hiroshi Arima, et al.. (2009). [Successful treatment of chronic disseminated intravascular coagulation syndrome with continuous subcutaneous infusion of heparin using a mobile infusion pump: report of 2 cases].. PubMed. 50(12). 1700–5. 7 indexed citations
11.
Tanaka, Yasuhiro, Yuya Nagai, Minako Mori, et al.. (2006). Multiple Granulocytic Sarcomas in Essential Thrombocythemia. International Journal of Hematology. 84(5). 413–416. 5 indexed citations
12.
Tanaka, Yasuhiro, Masayuki Kurata, Katsuhiro Togami, et al.. (2006). Chronic Eosinophilic Leukemia with the FIP1L1-PDGFRα Fusion Gene in a Patient with a History of Combination Chemotherapy. International Journal of Hematology. 83(2). 152–155. 10 indexed citations
13.
Tanaka, Yasuhiro, Kenichi Nagai, Naoko Watanabe, et al.. (2005). [Renal insufficiency caused by leukemic cell infiltration in Sézary syndrome].. PubMed. 46(5). 368–71. 1 indexed citations
14.
Watanabe, Naoko, Takayuki Takahashi, Naoshi Sugimoto, et al.. (2005). Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. International Journal of Clinical Oncology. 10(5). 357–361. 19 indexed citations
15.
Nishikori, Momoko, Yoshitomo Maesako, Chiyoko Ueda, et al.. (2003). High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease. Blood. 101(7). 2789–2796. 50 indexed citations
16.
Ueda, Chiyoko, Takashi Akasaka, Masayuki Kurata, et al.. (2002). The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma. Oncogene. 21(3). 368–376. 31 indexed citations
17.
Kurata, Masayuki, Yoshitomo Maesako, Chiyoko Ueda, et al.. (2002). Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.. PubMed. 62(21). 6224–30. 15 indexed citations
18.
Yonetani, Noboru, Masayuki Kurata, Momoko Nishikori, et al.. (2001). Primary Mediastinal Large B-Cell Lymphoma: A Comparative Study With Nodular Sclerosis—Type Hodgkin’s Disease. International Journal of Hematology. 74(2). 178–185. 4 indexed citations
19.
Akasaka, Takashi, Chiyoko Ueda, Masayuki Kurata, et al.. (2000). Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood. 96(8). 2907–2909. 64 indexed citations
20.
Akasaka, Takashi, Chiyoko Ueda, Masayuki Kurata, et al.. (2000). Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood. 96(8). 2907–2909. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Kreher Breakdown of academic impact, for papers by Maria Luisa Lombardi Breakdown of academic impact, for papers by Ayako Masaki Breakdown of academic impact, for papers by Kyohei Yamada Breakdown of academic impact, for papers by Quangeng Zhang Breakdown of academic impact, for papers by Barbara Hutter Breakdown of academic impact, for papers by J. Kimble Frazer Breakdown of academic impact, for papers by Yujie Wu Breakdown of academic impact, for papers by L Nagarajan Breakdown of academic impact, for papers by Benjamin E. Rich
Rankless by CCL
2026